A spatial approach to understanding drug dynamics using mass spectrometry imaging
Drug Target Review
JUNE 16, 2025
Multiomics MSI studies provide crucial insights into drug pharmacology and toxicity, supporting the development of innovative therapies including chimeric antigen receptor (CAR) T-cell treatments, oligonucleotide therapeutics, antibody drug conjugates (ADCs) and ribonucleic acid (RNA) therapeutics. Drug Discovery Today 2025, 30 (1), 104275.
Let's personalize your content